Genta is committed to identifying, developing, and commercializing innovative new products to treat patients with cancer and to address the unmet medical needs of those afflicted with this disease. The shareholders of Genta Incorporated are key partners in this endeavor, and we are very grateful for your investment and confidence in the Company.
To contact Genta Investor Relations, please send your inquiries via email to info@genta.com
The shareholders of Genta Incorporated are key partners in this endeavor, and we are very grateful for your investment and confidence in the Company. Genta is committed to keeping our shareholders apprised of new developments from our Company, and we value regular and timely communication with individuals and institutions who own our shares. To contact Genta Investor Relations, please send your inquiries via email to info@genta.com.
Read More
12th Annual BIO CEO & Investor ConferenceFebruary 8-9, 2010New York, NY
